|
EVMN Evommune Inc 2044725 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-21,674,000.00 |
| Balance Sheet |
|
Current Assets
|
$215,855,000.00 |
|
Assets
|
$322,455,000.00 |
|
Current Liabilities
|
$10,603,000.00 |
|
Liabilities
|
$17,900,000.00 |
|
Equity
|
$304,555,000.00 |
|
Shares Out
|
36018372.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-27,503,000.00 |
|
Investing Cash Flow
|
$-85,359,000.00 |
| Market Analysis |
Market Cap
|
$408,808,522.20 |
|
Price
|
$11.12 |
|
BVPS
|
8.46 |
|
PB
|
1.34 |
|
EPS
|
-0.64 |
|
FCF
|
$-27,586,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:27 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:23 |
|
| Apr |
May |
Jun |
| 2026-03-05 |
-1.43 |
|
|
2026-05-07 |
-0.64 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view EVMN documents filed with the SEC.
EVMN Filings
Clear
